title: First therapy targeting Parkinson's proteins enters clinical trials.
authors: Elie
authors: E
authors: Dolgin
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy; D010300:Parkinson Disease / Q000188:drug therapy* / Q000276:immunology; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D051844:alpha-Synuclein / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000906:Antibodies; D010455:Peptides; D051844:alpha-Synuclein